financial_news

Boca Raton, FL May 16, 2014 – Celsius Holdings, Inc., (OTC Pink: CELH) the creator and marketer of Celsius®, the world’s first and only negative calorie drink backed by clinical science, announced today that it has filed new disclosure documents including the Annual Report for the period ending December 31, 2013 as well as the Quarterly Report for the period ending March 31, 2014 with OTC Markets Group, Inc., to upgrade its listing status. 

Upon review of the filings and approval from OTC Markets, Celsius Holdings, Inc. will move to the OTC Pink Current Information tier of listed companies which is the highest trading tier on the OTC Pink marketplace. “We are very pleased to have achieved the highest tier in OTC Pink marketplace as it brings significant benefits to the Company and its shareholders with readily available comprehensive information on the Company’s operations and financials on OTC Markets. Completion of the upgrade to OTC Pink Current Information is a positive step Celsius Holdings, Inc has taken to strengthen our stockholder base and build stockholder value by providing greater transparency through periodic press release and quarterly and annual disclosures,” stated Gerry David, CEO of Celsius Holdings Inc. 

“In the past month, our team has been diligently working to remove the Stop sign on the OTC Markets and the amount of work and resources that that went into ‘Going Current’ was significant as we completed a comprehensive preparation and review of the books, records and disclosure statement of the Company going back to 2012,” said Gerry David

About Celsius Holdings, Inc. 

Celsius Holdings, Inc. (Other OTC: CELH.PK) markets Celsius®, which is backed by science. Celsius is dedicated to providing healthier, everyday refreshment through science and innovation. For more information, please visit www.celsius.com. 

Forward-Looking Statements 

This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings' future results of operations and/or financial position, or state other forward-looking information. In some cases you can identify these statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will,”, “would,” or similar words. You should not rely on forward-looking statements since Celsius Holdings' actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include, but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business; and other risks and uncertainties discussed in the reports Celsius Holdings has filed previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release 

(download in pdf format)

Contact information: 

John Fieldly, CFO, 

(866) 4-CELSIUS, (561) 276-2239, 

 jfieldly@celsius.com 

 

Media Contact: 

 5W Public Relations 

(646) 763-8878 

Jacolyn Gleason 

FOR IMMEDIATE RELEASE jgleason@5wpr.com

Print Friendly
Logo_footer   
  © 2015 Celsius. All rights reserved.

†Celsius alone does not produce weight loss in the absence of a healthy diet and moderate exercise. In a 10 week published university clinical study in the Journal of International Society of Sports Nutrition with sedentary men and women, the group who drank one Celsius per day experienced Significantly Better Results.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Privacy Policy

Follow us: